Rating History for Avalyn Pharma (AVLN) by Raymond James
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 10/2/2026 | Tiago Fauth | New Coverage | Outperform (N/A) |
60.00 (N/A) |
27.42 (25.35) |
-7.55% | Details |
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 10/2/2026 | Tiago Fauth | New Coverage | Outperform (N/A) |
60.00 (N/A) |
27.42 (25.35) |
-7.55% | Details |